HYZAAR DS 100 MG
LOSARTAN POTASSIUM : 100 MG HYDROCHLOROTHIAZIDE : 25 MG · DIN 02241007 · ORGANON CANADA INC.
Health Canada status: MARKETED
What is HYZAAR DS?
HYZAAR DS 100 MG contains LOSARTAN POTASSIUM : 100 MG HYDROCHLOROTHIAZIDE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02241007, held by ORGANON CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 01-Apr-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is HYZAAR DS used for?
HYZAAR (losartan potassium and hydrochlorothiazide) is indicated for: • the treatment of essential hypertension in patients for whom combination therapy is appropriate HYZAAR is not indicated as the initial therapy for essential hypertension, except in patients with severe essential hypertension (Sitting DBP ≥110 mmHg) for whom the benefit of a prompt blood pressure reduction exceeds the risk of initiating combination therapy in these patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is HYZAAR DS called?
The same molecule, LOSARTAN AND DIURETICS, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Losartan Medical Valley | Latin | Sweden |
| Losartan Krka | Latin | Sweden |
| Losartan Teva | Latin | Sweden |
| Losartan/Hydrochlorothiazide Krka | Latin | Sweden |
| Losartan Viatris | Latin | Sweden |
| Losartan/Hydrochlorothiazide Medical Valley | Latin | Sweden |
| LOSARTAN GT | Latin | Morocco |
| Losartan STADA | Latin | Sweden |
| Losartan/Hydrochlorothiazide Teva | Latin | Sweden |
| COZAAR | Latin | Morocco |
| ANGINIB | Latin | Morocco |
| LACINE | Latin | Morocco |
| Losarstad Comp | Latin | Sweden |
| Losartan Sandoz | Latin | Sweden |
| Losartan/Hydrochlorothiazide STADA | Latin | Sweden |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02241007 |
|---|---|
| Brand name | HYZAAR DS |
| Generic / active ingredient | LOSARTAN POTASSIUM : 100 MG HYDROCHLOROTHIAZIDE : 25 MG |
| Manufacturer | ORGANON CANADA INC. |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA01 LOSARTAN AND DIURETICS |
| AHFS class | 40:28.20 ; 24:32.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Apr-2022 |
| Original market date | 2000-01-21 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02241007 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2241007 |
| Brand name | HYZAAR DS |
| Active ingredient / INN | LOSARTAN POTASSIUM : 100 MG HYDROCHLOROTHIAZIDE : 25 MG |
| ATC code | C09DA01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09 |
| AHFS class | 40:28.20 ; 24:32.08 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | ORGANON CANADA INC. |
How is it stored and handled?
null
How is it supplied?
push-through blister packages of 30 tablets
Which pack is which?
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | push-through blister packages of 30 tablets |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is LOSARTAN AND DIURETICS in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C09DA01 LOSARTAN AND DIURETICS. 21 of 53 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-LOSARTAN HCT | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02423669 |
| AURO-LOSARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02423650 |
| AURO-LOSARTAN HCT | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02423642 |
| HYZAAR | 100 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02297841 |
| HYZAAR | 50 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02230047 |
| LOSARTAN HCT | 100 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388979 |
| LOSARTAN HCT | 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388960 |
| LOSARTAN HCT DS | 25 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388987 |
| LOSARTAN/HCTZ | 12.5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02427656 |
| LOSARTAN/HCTZ | 25 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02427664 |
Who else supplies LOSARTAN AND DIURETICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LOSARTAN AND DIURETICS appears in 4256 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does LOSARTAN AND DIURETICS cost around the world?
LOSARTAN AND DIURETICS is listed on 12 national price registers Nexara tracks, across 303 pack listings published on 11 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 3 | 118 | 03 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 13 | 57 | 03 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 16 | 37 | 02 Sep 2026 |
| Greece | producer price (ex-factory) | 19 | 19 | 03 Sep 2026 |
| Morocco | PPV (public price) | 7 | 16 | 05 Sep 2026 |
| South Africa | single exit price | 16 | 16 | 01 Sep 2026 |
| Belgium | public | 12 | 12 | 01 Sep 2026 |
| Hungary | producer price (ex-factory) | 12 | 12 | 03 Sep 2026 |
| Slovakia | categorised final price | 5 | 8 | 02 Sep 2026 |
| Romania | max producer price | 3 | 4 | 03 Sep 2026 |
| United Kingdom | hospital | 3 | 3 | 31 Aug 2026 |
| Spain | PVP con IVA (public price) | 1 | 1 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.